Table 2.
study model | study type | study | study population | analysis carried out | metabolic changes observed |
|
---|---|---|---|---|---|---|
upregulated | downregulated | |||||
bovine | 2-day culture, IVF-derived and parthenogenetic-activated embryos | Rubessa et al. [110] | CL 20, BL 20, | blastocyst development | Cit, Pyr and Lys | Myo-inositol |
IVF 20, PA 20 | IVF versus PA | Phe | ↓OAc | |||
individual culture and group culture (30/drop) | Perkel et al. [111] | 113 | fast-growing and slow-growing embryos | 4 cell-Pyr | 4 cell: n.a. | |
8 cell and 16 cell: His, Trp, Val | 8 cell and 16 cell: n.a. | |||||
2 cell and 16 cell: Ile, Leu | 2 cell and 16 cell: n.a. | |||||
group culture system | Rubessa et al. [83] | male 20, female 20 | sex determination of embryo at early (1–3 days) and late development stage (5–7 days) | 1–2 days: Val | 1–2 days: n.a. | |
5–7 days: n.a. | 5–7 days: Pyr | |||||
mouse | group culture (10/drop) | D'Souza et al. [112] | 185 | embryo carrying induced DNA lesion on day 3.5 | Glc, Lac, Pyr, Thy, Pro, Val, Ala, Ile and Lys | n.a. |
individual culture | D'Souza et al. [93] | 118 | blastocyst in vitro outgrowth | Pyr and Lac | Pyr/Ala | |
individual culture | D'Souza et al. [113] | 90 | blastocyst | Pyr | Ala, Pyr/Ala and Pyr/Lac |